Research Topic: Medicinal

Health benefits of fish and fish by-products—a nutritional and functional perspective

Fish is an excellent food that provides many important nutrients like protein, omega-3 fatty acids, and vitamins that help protect our hearts, brains, and overall health. Different fish species offer various health benefits including protecting against heart disease, diabetes, obesity, and brain disorders. However, some fish can contain harmful contaminants like mercury, so choosing safer options like salmon and cod is important for children and pregnant women.

Read More »

Fungal β-Glucans Enhance Lactic Acid Bacteria Growth by Shortening Their Lag Phase and Increasing Growth Rate

Researchers tested whether extracts from common edible mushrooms like oyster and shiitake could help beneficial bacteria in the gut grow better. They found that these mushroom extracts, particularly their β-glucan components, helped probiotic bacteria start growing faster and grow more quickly. Importantly, the extracts did not help harmful bacteria grow, making them promising candidates for developing healthier food supplements that support gut health.

Read More »

Bioactive Peptides from Quinoa (Chenopodium quinoa Willd.) as Modulators of the Gut Microbiome: A Scoping Review of Preclinical Evidence

This review examines how quinoa and its protein-derived peptides can improve gut health by changing the balance of bacteria in the digestive system. Research shows that quinoa helps boost beneficial bacteria, increases diversity of microbial communities, and promotes production of butyrate, a beneficial compound that supports intestinal health. Different disease conditions show specific improvements, such as reduced harmful bacteria in colitis and better metabolic balance in obesity, suggesting quinoa could be tailored for personalized health interventions.

Read More »

Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication

Researchers tested whether people with severe depression could take psilocybin (a compound from certain mushrooms) while staying on their antidepressant medications. In this study of 19 people, those who received psilocybin with psychological support while continuing their SSRI showed significant improvement in depression symptoms over three weeks, with response rates of 42%. Side effects were mostly mild and temporary, suggesting this approach may be safe and effective without requiring patients to stop their current antidepressants.

Read More »

Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: An fMRI pilot study

This pilot study examined how psilocybin affects the brains of people with alcohol use disorder. Using brain imaging (fMRI), researchers found that psilocybin increased activity in brain regions associated with decision-making and emotional control while decreasing activity in regions linked to cravings. These findings suggest psilocybin may help people with alcohol addiction by enhancing their ability to regulate emotions and resist urges to drink.

Read More »

Sex-Specific Associations Between Prebiotic Supplement Intake and Sarcopenia Risk: Evidence From NHANES

This study examined whether taking prebiotic supplements helps prevent sarcopenia (age-related muscle loss) differently in men versus women using health data from thousands of Americans. Researchers found that women who consumed prebiotics had significantly lower rates of sarcopenia, while this benefit was not observed in men. These findings suggest that prebiotic supplements may be particularly beneficial for women’s muscle health, though more research is needed to understand why this sex difference exists.

Read More »

Ethical Considerations Regarding Psychedelics for Clinical Pain Research

This paper examines the ethical considerations necessary when conducting research on psychedelics like psilocybin for treating chronic pain. With chronic pain affecting millions of Americans and traditional treatments like opioids causing significant problems, researchers are exploring psychedelics as alternatives. The authors provide guidance on obtaining proper informed consent, protecting vulnerable patients, managing regulatory requirements, and ensuring research benefits participants while following four key ethical principles: autonomy, beneficence, justice, and avoiding harm.

Read More »

Light-responsive transcription factor CmOzf integrates conidiation, fruiting body development, and secondary metabolism in Cordyceps militaris

Scientists studied a medicinal fungus called Cordyceps militaris and discovered that a protein called CmOzf acts as a master controller of several important processes. When light shines on the fungus, it activates CmOzf, which helps the fungus produce spores for reproduction through a specific genetic pathway. Interestingly, when CmOzf is blocked, the fungus produces fewer spores but makes more pigments and beneficial compounds. This discovery could help improve the production of medicinal compounds from this fungus and its use as a natural pest control agent.

Read More »

Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders

This comprehensive review explores how psychedelic drugs like psilocybin mushrooms, DMT, and LSD may offer new hope for treating depression, anxiety, and PTSD, especially for patients who don’t respond to conventional antidepressants. Historically used in spiritual ceremonies for thousands of years, these compounds are now being scientifically studied and show promise with fewer side effects than many traditional psychiatric medications. The authors emphasize that while results are encouraging, more research and regulatory approval are needed before these treatments become widely available in mainstream medicine.

Read More »
Scroll to Top